Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:APHA TSE:AUP NYSE:BHC NYSE:PBH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAPHAAphria$15.38$15.48$2.78▼$32.29$4.87B2.6721.83 million shsN/AAUPAurinia PharmaceuticalsC$0.00C$11.77▼C$26.00C$2.15BN/A229,895 shs4.61 million shsBHCBausch Health Cos$7.35+1.9%$6.84$4.25▼$9.85$2.72B0.484.75 million shs1.01 million shsPBHPrestige Consumer Healthcare$65.06-2.5%$72.04$62.95▼$90.04$3.20B0.46617,635 shs693,488 shsThe 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAPHAAphria0.00%0.00%0.00%0.00%0.00%AUPAurinia Pharmaceuticals0.00%0.00%0.00%0.00%0.00%BHCBausch Health Cos0.00%-0.88%+27.63%+54.63%+18.09%PBHPrestige Consumer Healthcare0.00%-4.47%-3.90%-23.55%-13.82%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAPHAAphria$15.38$15.48$2.78▼$32.29$4.87B2.6721.83 million shsN/AAUPAurinia PharmaceuticalsC$0.00C$11.77▼C$26.00C$2.15BN/A229,895 shs4.61 million shsBHCBausch Health Cos$7.35+1.9%$6.84$4.25▼$9.85$2.72B0.484.75 million shs1.01 million shsPBHPrestige Consumer Healthcare$65.06-2.5%$72.04$62.95▼$90.04$3.20B0.46617,635 shs693,488 shsThe 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAPHAAphria0.00%0.00%0.00%0.00%0.00%AUPAurinia Pharmaceuticals0.00%0.00%0.00%0.00%0.00%BHCBausch Health Cos0.00%-0.88%+27.63%+54.63%+18.09%PBHPrestige Consumer Healthcare0.00%-4.47%-3.90%-23.55%-13.82%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAPHAAphria 0.00N/AN/AN/AAUPAurinia Pharmaceuticals 0.00N/AN/AN/ABHCBausch Health Cos 2.00Hold$9.0022.53% UpsidePBHPrestige Consumer Healthcare 2.29Hold$93.3343.45% UpsideCurrent Analyst Ratings BreakdownLatest PBH, APHA, BHC, and AUP Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails9/4/2025PBHPrestige Consumer HealthcareZacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold ➝ Strong Sell8/8/2025PBHPrestige Consumer HealthcareCanaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$105.00 ➝ $100.00(Data available from 9/7/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAPHAAphria$405.96M12.00$0.09 per share166.43$4.80 per share3.20AUPAurinia PharmaceuticalsC$57.59M0.00N/A6.75C$2.59 per share0.00BHCBausch Health Cos$9.86B0.28$7.73 per share0.95($0.89) per share-8.25PBHPrestige Consumer Healthcare$1.14B2.81$5.21 per share12.48$37.04 per share1.76Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAPHAAphria-$63.21M-$0.06N/A219.71N/A-36.10%-2.30%-1.66%N/AAUPAurinia PharmaceuticalsN/A-C$1.48N/AN/AN/AN/AN/AN/AN/ABHCBausch Health Cos-$46M$0.2628.251.58N/A0.99%-852.36%5.25%10/29/2025 (Estimated)PBHPrestige Consumer Healthcare$214.60M$4.2615.2713.672.0619.02%12.69%6.79%11/6/2025 (Estimated)Latest PBH, APHA, BHC, and AUP EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/7/2025Q1 2026PBHPrestige Consumer Healthcare$1.01$0.95-$0.06$0.95$260.71 million$249.53 million7/30/2025Q2 2025BHCBausch Health Cos$0.97$0.90-$0.07$0.40$2.47 billion$2.57 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAPHAAphriaN/AN/AN/AN/AN/AAUPAurinia PharmaceuticalsN/AN/AN/AN/AN/ABHCBausch Health CosN/AN/AN/AN/AN/APBHPrestige Consumer HealthcareN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAPHAAphria0.252.361.17AUPAurinia Pharmaceuticals2.6911.9311.02BHCBausch Health Cos141.901.310.98PBHPrestige Consumer Healthcare0.554.382.99Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAPHAAphria10.30%AUPAurinia PharmaceuticalsN/ABHCBausch Health Cos78.65%PBHPrestige Consumer Healthcare99.95%Insider OwnershipCompanyInsider OwnershipAPHAAphriaN/AAUPAurinia PharmaceuticalsN/ABHCBausch Health Cos19.97%PBHPrestige Consumer Healthcare1.40%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAPHAAphria1,200316.80 millionN/AOptionableAUPAurinia Pharmaceuticals300128.40 millionN/ANot OptionableBHCBausch Health Cos20,700370.35 million296.39 millionOptionablePBHPrestige Consumer Healthcare54049.21 million48.53 millionOptionablePBH, APHA, BHC, and AUP HeadlinesRecent News About These CompaniesBridgeway Capital Management LLC Has $5.89 Million Stake in Prestige Consumer Healthcare Inc. $PBH2 hours ago | marketbeat.comPrestige Consumer Healthcare Inc. $PBH Position Lessened by Ariel Investments LLCSeptember 5 at 7:19 AM | marketbeat.comPrestige Consumer Healthcare Inc. (PBH) Presents at Barclays 18th Annual Global Consumer Staples Conference 2025 TranscriptSeptember 5 at 2:00 AM | seekingalpha.comPrestige Consumer Healthcare (PBH) Presents at the Barclays Global Consumer Staples ConferenceSeptember 5 at 2:18 AM | seekingalpha.comPrestige Consumer Healthcare: Elevated Debt And Limited Growth ProspectsSeptember 4 at 9:29 PM | seekingalpha.comPrestige Consumer Healthcare to Present at the Barclays Global Consumer Staples ConferenceSeptember 4 at 7:00 AM | globenewswire.comPrestige Consumer Healthcare Inc. $PBH Shares Sold by The Manufacturers Life Insurance CompanySeptember 3, 2025 | marketbeat.comOMERS ADMINISTRATION Corp Takes $997,000 Position in Prestige Consumer Healthcare Inc. $PBHSeptember 3, 2025 | marketbeat.comJane Street Group LLC Raises Stake in Prestige Consumer Healthcare Inc. $PBHSeptember 3, 2025 | marketbeat.comComerica Bank Sells 14,074 Shares of Prestige Consumer Healthcare Inc. $PBHSeptember 3, 2025 | marketbeat.comMagnetar Financial LLC Invests $1.43 Million in Prestige Consumer Healthcare Inc. $PBHSeptember 2, 2025 | marketbeat.comZacks Research Issues Pessimistic Forecast for PBH EarningsAugust 31, 2025 | marketbeat.comZacks Research Has Bearish Forecast for PBH Q3 EarningsAugust 31, 2025 | americanbankingnews.comPrice T Rowe Associates Inc. MD Has $40.08 Million Position in Prestige Consumer Healthcare Inc. $PBHAugust 30, 2025 | marketbeat.comHsbc Holdings PLC Sells 9,406 Shares of Prestige Consumer Healthcare Inc. $PBHAugust 29, 2025 | marketbeat.comCampbell & CO Investment Adviser LLC Buys 6,054 Shares of Prestige Consumer Healthcare Inc. $PBHAugust 28, 2025 | marketbeat.comNorthern Trust Corp Purchases 39,198 Shares of Prestige Consumer Healthcare Inc. $PBHAugust 28, 2025 | marketbeat.comVirtus Advisers LLC Invests $888,000 in Prestige Consumer Healthcare Inc. $PBHAugust 27, 2025 | marketbeat.comKayne Anderson Rudnick Investment Management LLC Boosts Holdings in Prestige Consumer Healthcare Inc. $PBHAugust 26, 2025 | marketbeat.comNuveen LLC Acquires New Holdings in Prestige Consumer Healthcare Inc. $PBHAugust 26, 2025 | marketbeat.comPremium Brands: Long Climb To $10 BillionAugust 25, 2025 | seekingalpha.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimePBH, APHA, BHC, and AUP Company DescriptionsAphria NASDAQ:APHAAphria Inc. cultivates, processes, produces, markets, distributes, and sells medical cannabis in Canada and internationally. The company offers pharmaceutical-grade medical cannabis, adult-use cannabis, and cannabis-derived extracts and derivative cannabis products under the Solei, RIFF, Good Supply, Aphria, P'tite Pof, and Broken Coast brands. It serves patients and consumers through distributors and online. The company is headquartered in Leamington, Canada.Aurinia Pharmaceuticals TSE:AUPAurinia Pharmaceuticals Inc., a biopharmaceutical company, develops and commercializes therapies to treat various diseases with unmet medical need in Japan and China. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company is headquartered in Victoria, Canada.Bausch Health Cos NYSE:BHC$7.34 +0.14 (+1.87%) Closing price 09/5/2025 03:59 PM EasternExtended Trading$7.35 +0.00 (+0.07%) As of 09/5/2025 07:08 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; generic products; ortho dermatologic; and dentistry products in the United States. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.Prestige Consumer Healthcare NYSE:PBH$65.06 -1.69 (-2.53%) Closing price 09/5/2025 03:59 PM EasternExtended Trading$65.06 +0.00 (+0.00%) As of 09/5/2025 06:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 09/01 - 09/05 Lululemon Share Price Has Plenty of Room Left to Fall Why DocuSign Could Be a SaaS Value Play After Q2 Earnings Why Hedge Fund Elliott Bet $4B on Pepsi and Sees Over 50% Upside Palantir Insider Selling: Risk Signal or Normal Activity? Advanced Micro Devices' 2026 Forecasts Are Way Too Low Salesforce Stumbles, But Investors Eye a Major Comeback Buy the Dip? GitLab’s Bullish Case Outweighs the Bears Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
